Who owns Quest Diagnostics Incorporated?
The parent company, the largest shareholders that report their holdings, the funds that own Quest Diagnostics Incorporated and what its insiders traded, each from the filing that states it.
The short answer
Quest Diagnostics Incorporated is a listed company: its shares trade on NYSE, so it is owned by its shareholders, and the GLEIF register names no parent company.
1,139 institutional investors that report to the SEC on Form 13F held 93.3% of its shares on Sep 30, 2026.
The largest of them was BlackRock, Inc. with 8.41%, followed by Vanguard Capital Management LLC (6.57%) and Vanguard Portfolio Management LLC (5.56%).
696 mutual funds registered in 3 countries held 41.0% of the company in their latest reports (the newest of Oct 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's.
In the last 12 months its insiders reported no purchases and 41 sales worth $47 M on SEC Form 4.
Newest figure: Oct 31, 2026.
Holdings reported on SEC Form 13F for the quarter ended Sep 30, 2026: 1,139 holders, 93.3% of the shares together.
| # | Holder | Of the shares | Value | Shares | Change in the quarter |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.41% | $2.2 B | 9.3 M | -0.3% |
| 2 | Vanguard Capital Management LLC | 6.57% | $1.7 B | 7.2 M | -0.1% |
| 3 | Vanguard Portfolio Management LLC | 5.56% | $1.4 B | 6.1 M | -0.3% |
| 4 | State Street Corp | 5.05% | $1.3 B | 5.6 M | +0.7% |
| 5 | Price T Rowe Associates Inc /MD/ | 4.56% | $1.2 B | 5.0 M | -7.8% |
| 6 | Boston Partners | 4.22% | $1.1 B | 4.6 M | -2.2% |
| 7 | FMR LLC | 4.10% | $1.1 B | 4.5 M | +222.7% |
| 8 | Geode Capital Management, LLC | 2.88% | $738 M | 3.2 M | +0.9% |
| 9 | Jpmorgan Chase & Co | 2.63% | $673 M | 2.9 M | -18.0% |
| 10 | Morgan Stanley | 2.24% | $575 M | 2.5 M | +0.3% |
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Filings read up to Nov 18, 2026; the quarter is still being filed (99% of last quarter's holders so far). People who hold shares in their own name, such as founders, are not in 13F reports
How ownership moved#
Institutions held 93.3% of Quest Diagnostics Incorporated at Sep 30, 2026, down 1.76 points from Jun 30, 2026; 34 more institutions.
| Quarter end | Institutions | Share of the company | Shares bought | Shares sold | Positions opened | Positions closed |
|---|---|---|---|---|---|---|
| Sep 30, 2026(still being filed) | 1,139 | 93.3% | 7.4 M | 7.0 M | 126 | 109 |
| Jun 30, 2026 | 1,105 | 95.1% | 6.3 M | 5.0 M | 105 | — |
| Mar 31, 2026 | 1,057 | 92.2% | — | — | — | — |
| Dec 31, 2025 | 1,033 | 96.4% | — | — | — | — |
| Sep 30, 2025 | 981 | 98.0% | — | — | — | — |
| Jun 30, 2025 | 964 | 95.8% | — | — | — | — |
| Mar 31, 2025 | 939 | 90.9% | — | — | — | — |
| Dec 31, 2024 | 870 | 89.0% | — | — | — | — |
| Sep 30, 2024 | 825 | 86.4% | — | — | — | — |
| Jun 30, 2024 | 817 | 87.2% | — | — | — | — |
| Mar 31, 2024 | 785 | 87.4% | — | — | — | — |
| Dec 31, 2023 | 795 | 88.0% | — | — | — | — |
| Sep 30, 2023 | 771 | 86.3% | — | — | — | — |
| Jun 30, 2023 | 788 | 87.6% | — | — | — | — |
| Mar 31, 2023 | 798 | 87.6% | — | — | — | — |
| Dec 31, 2022 | 851 | 88.3% | — | — | — | — |
| Sep 30, 2022 | 780 | 88.8% | — | — | — | — |
| Jun 30, 2022 | 825 | 87.7% | — | — | — | — |
| Mar 31, 2022 | 821 | 88.5% | — | — | — | — |
| Dec 31, 2021 | 875 | 87.1% | — | — | — | — |
| Sep 30, 2021 | 811 | 88.0% | — | — | — | — |
Bought most, quarter to Sep 30, 2026
- FMR LLC+3.1 M
- Invesco Ltd.+357,513
- Citadel Advisors LLC+298,436
- Goldman Sachs Group Inc+275,200
- Squarepoint Ops LLC+253,766
- FIL Ltd+213,687
- Jane Street Group, LLC+200,668
- Los Angeles Capital Management LLC+131,084
Sold most
- Jpmorgan Chase & Co−632,402
- Victory Capital Management Inc−574,424
- Woodline Partners LP−478,339
- Price T Rowe Associates Inc /MD/−423,982
- American Century Companies Inc−418,412
- Balyasny Asset Management L.P.−272,206
- UBS Group AG−247,859
- Davis Selected Advisers−229,974
New positions (shares held)
- Gilder Gagnon Howe & Co LLC208,595
- Samlyn Capital, LLC117,407
- Wilshire Advisors LLC60,368
- Two Sigma Investments, LP59,561
- HRT Financial LP57,841
- ExodusPoint Capital Management, LP51,737
- Sapient Capital LLC32,609
- Capital Fund Management S.A.22,781
Insiders' open-market purchases (up) and sales (down), by quarter
Source: SEC Form 13F data sets and Forms 4 and 5. Institutions report three months after each quarter; a quarter's purchases and sales add up each institution's change since its report for the quarter before. Insiders' trades count open-market purchases and sales only, in the company's reporting currency. 722 mutual funds and ETFs hold Quest Diagnostics Incorporated in their latest reports: 55 new, 221 adding, 301 cutting.
696 funds in 3 countries held 41.0% of the company in their latest reports. Fund holdings are part of what their managers report on Form 13F, so do not add the two.
| Fund | Manager | Country | Of the company | Value | Report of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 3.19% | $745 M | Jun 30, 2026 |
| Vanguard 500 Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 2.61% | $608 M | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 2.18% | $508 M | Jun 30, 2026 |
| iShares Core S&P 500 ETF | BlackRock Fund Advisors | 🇺🇸 | 1.38% | $322 M | Jun 30, 2026 |
| State Street SPDR S&P 500 ETF Trust | State Street(R) SPDR(R) S&P 500(R) ETF Trust | 🇺🇸 | 1.22% | $284 M | Jun 30, 2026 |
Source: Fund portfolios filed with regulators (SEC Form N-PORT and others) · as of Oct 31, 2026
- Purchases
- 0
- Sales
- 41
- Bought
- $0 M
- Sold
- $47 M
What Quest Diagnostics Incorporated owns
Companies it owns directly (3 in the GLEIF register)
- Blueprint Genetics Oy FI, ESPOO
- QUEST DIAGNOSTICS HTAS INDIA PRIVATE LIMITED IN, HYDERABAD
- QUEST DIAGNOSTICS INDIA PRIVATE LIMITED IN, GURGAON
Questions and answers#
Who owns Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated is a listed company: its shares trade on NYSE, so it is owned by its shareholders, and the GLEIF register names no parent company. 1,139 institutional investors that report to the SEC on Form 13F held 93.3% of its shares on Sep 30, 2026. The largest of them was BlackRock, Inc. with 8.41%, followed by Vanguard Capital Management LLC (6.57%) and Vanguard Portfolio Management LLC (5.56%).
Who is the largest shareholder of Quest Diagnostics Incorporated?
Among investors that file SEC Form 13F, BlackRock, Inc. was the largest on Sep 30, 2026, with 8.41% of the shares. Founders, executives and other people who hold shares in their own name report them on SEC Forms 3, 4 and 5 and in the proxy statement, not on Form 13F, so they are not in this ranking.
How much of Quest Diagnostics Incorporated do institutional investors own?
1,139 institutional investors that report to the SEC on Form 13F held 93.3% of its shares on Sep 30, 2026.
Does Quest Diagnostics Incorporated have a parent company?
No. The GLEIF register of legal entities names no parent company of Quest Diagnostics Incorporated.
What companies and brands does Quest Diagnostics Incorporated own?
The GLEIF register lists 3 companies that Quest Diagnostics Incorporated owns directly, among them Blueprint Genetics Oy, QUEST DIAGNOSTICS HTAS INDIA PRIVATE LIMITED and QUEST DIAGNOSTICS INDIA PRIVATE LIMITED.
Which mutual funds own Quest Diagnostics Incorporated?
696 mutual funds registered in 3 countries held 41.0% of the company in their latest reports (the newest of Oct 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's. Funds' holdings are part of what their managers report on Form 13F, so the two shares overlap.
Sources#
Every figure on this page comes from these, with the date shown next to it.
- GLEIF LEI register, level 2 (who owns whom)
- SEC Form 13F holdings reports
- Fund portfolios filed with regulators (SEC Form N-PORT, Brazil CVM, Sweden Finansinspektionen, Indian fund houses)
- SEC Forms 3, 4 and 5 (insider transactions)
More about Quest Diagnostics Incorporated#
Questions people ask
Compare head to head
Similar companies by size and industry
- Philips$26.8 B
- Labcorp Holdings Inc.$26.3 B
- DexCom, Inc.$29.9 B
- Guardant Health, Inc.$24.1 B
- Mettler-Toledo International Inc.$32.5 B
- Illumina, Inc.$40.7 B